Matches in Wikidata for { <http://www.wikidata.org/entity/Q74283090> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q74283090 description "clinical trial" @default.
- Q74283090 description "ensayu clínicu" @default.
- Q74283090 description "klinisch onderzoek" @default.
- Q74283090 description "клінічне випробування" @default.
- Q74283090 name "The Safety, Tolerability, and Initial Efficacy of HX009 in Patients With Advanced Malignancies" @default.
- Q74283090 name "The Safety, Tolerability, and Initial Efficacy of HX009 in Patients With Advanced Malignancies" @default.
- Q74283090 type Item @default.
- Q74283090 label "The Safety, Tolerability, and Initial Efficacy of HX009 in Patients With Advanced Malignancies" @default.
- Q74283090 label "The Safety, Tolerability, and Initial Efficacy of HX009 in Patients With Advanced Malignancies" @default.
- Q74283090 prefLabel "The Safety, Tolerability, and Initial Efficacy of HX009 in Patients With Advanced Malignancies" @default.
- Q74283090 prefLabel "The Safety, Tolerability, and Initial Efficacy of HX009 in Patients With Advanced Malignancies" @default.
- Q74283090 P1132 Q74283090-24696C70-5BB7-4064-9B52-CF776900B98C @default.
- Q74283090 P1476 Q74283090-DDDA7D81-20E1-4D7B-9FA2-31A5C3DC98F8 @default.
- Q74283090 P17 Q74283090-CE74A2DF-1E26-49EC-8663-978D1CEFAC11 @default.
- Q74283090 P2899 Q74283090-849E68E6-D3D0-4ABF-9D2D-3E4EF8384633 @default.
- Q74283090 P3098 Q74283090-CABF61B9-54DA-4FDC-9711-56528A477F9C @default.
- Q74283090 P31 Q74283090-C51DD60B-121C-4BAD-BA1B-9317410627A2 @default.
- Q74283090 P4135 Q74283090-087A4E71-2B0B-4648-A05B-D9C203428E21 @default.
- Q74283090 P580 Q74283090-719EC70F-D05E-4140-9B15-9529BF10AFB2 @default.
- Q74283090 P582 Q74283090-046E975E-D567-42F0-859B-D197CE586C3E @default.
- Q74283090 P6099 Q74283090-405E3A49-2CC1-4C93-97F1-48139E4B0D5B @default.
- Q74283090 P8363 Q74283090-6A6FBAB3-FD3C-402B-8312-77F6321EE6CE @default.
- Q74283090 P1132 "+37" @default.
- Q74283090 P1476 "A Phase I, First-in-Human Study Evaluating the Safety, Tolerability, and Initial Efficacy of HX009 in Patients With Advanced Malignancies" @default.
- Q74283090 P17 Q408 @default.
- Q74283090 P2899 "+18" @default.
- Q74283090 P3098 "NCT04097769" @default.
- Q74283090 P31 Q30612 @default.
- Q74283090 P4135 "+70" @default.
- Q74283090 P580 "2019-06-12T00:00:00Z" @default.
- Q74283090 P582 "2021-06-12T00:00:00Z" @default.
- Q74283090 P6099 Q5452194 @default.
- Q74283090 P8363 Q78089383 @default.